The MarketWatch News Department was not involved in the creation of this content. MISSISSAUGA, ON, April 7, 2026 /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have ...
Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/) HO Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings ...
Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.
Amgen is scheduled to report its first-quarter results next week, and analysts expect a single-digit earnings dip.
Cardiovascular care is transitioning from primarily managing acute conditions to focusing on prevention and interventions for ...
VESALIUS-CV data supported evolocumab reducing MACE in high-risk primary prevention diabetes over 4.8 years, reinforcing the long-term outcome value of intensive LDL-C lowering. Merck’s oral PCSK9 ...
While prominent physicians can provide companies with valuable guidance during development, their perspective is limited when ...
Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha ...
Amgen Inc. (NASDAQ:AMGN) is one of the best pharma stocks to invest in now. Amgen Inc. (NASDAQ:AMGN) announced on March 28 that Repatha® lowered the risk of first major adverse cardiovascular events ...
Bristol Myers Squibb is adding three prescription medications on TrumpRx.gov on Monday, offering discounts of up to 90%, FOX Business has learned.
Amgen (AMGN) stock climbs as MariTide GLP-1 trials demonstrate nearly 20% weight loss. Truist raises price target to $325 amid growing optimism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results